An observational study in Osteoporotic Fractures, sponsored by Universidad de Valparaiso. Completed at 1 site in Chile. Open to participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-16.
Sponsored by Universidad de Valparaiso · Observational
Osteoporosis is a skeletal disease leading to bone fragility and increasing the risk of fractures and still remains a major public health problem worldwide. Therefore it is crucial to prevent severe fractures responsible for excess of mortality and considerable morbidity. Patient at risk of fractures are currently identified as having osteoporosis using Dual-energy X-ray Absorptiometry (DXA), assessing the areal or projected Bone Mineral Density (aBMD g.cm-2). In Chile, the hip fracture occurrence is very similar to the international incidence. Due to the demographic and epidemiological transition, the number of hip fracture for patient older than 50 year, is expected to severely increase from about 6.500 (2007) to 30.000 (2050) without adequate preventive and / or therapeutic measures.
Even if DXA remains the current gold standard, it is limited by the difficulty to set a threshold in the BMD distribution for osteoporosis diagnosis. Moreover, some medical conditions (chronic kidney disease, diabetes) or drugs (glucocorticoids) are associated with an increase of fracture risk without a BMD decrease. Quantitative ultrasound (QUS) have the advantages of portability, low cost, absence of radiation and need for a radiographic technologist or designated room, and are sensitive to both elasticity and geometry of the medium explored by the waves. Among QUS techniques, axial transmission (AT) is a technique for which transducers are aligned along the bone axis. Measured ultrasonic guided waves, associated with an appropriate waveguide model have the potential to yield estimates of material and/or geometrical cortical properties. In vivo combined estimation of both cortical thickness and porosity has been proposed using bidirectional axial transmission (BDAT). BDAT measurement has been recently validated on ex vivo specimen (radius and tibia) and has been tested in a pilot clinical study, in which cortical porosity measured at the one-third distal radius has been found as discriminant of low trauma fractures as DXA. Cortical porosity is increasingly recognized as a major contributor to bone fragility.
The hypothesis underlying this project are that (1) it is possible to obtain robust and accurate estimates of cortical thickness and porosity using an improved BDAT device and (2) these estimates are of clinical interest in the context of osteoporosis in elderly. Moreover, novel parameters obtained from automatic classification tools will be tested.
The purpose of this investigation is to determine if there are differences in the quantities of cortical bone (thickness and porosity) as well as the new parameters measured by BDAT at both forearm and leg, between patients with recent non traumatic fracture and controls.
Results will be compared to the current gold standard dual-energy X-ray absorptiometry (DXA) of the hip, spine and forearm, obtained from all subjects. The BDAT device with the improved interface will be tested in a clinical environment by clinical operators on:
DXA measurement will be done at the imaging center of the Universidad Catolica de Valparaiso (PUCV, FONDEQUIP EQM160142). Additional DXA parameters concerning muscle and fat, will be taken into account.
87 studies on the registry are indexed under Osteoporotic Fractures; 22 are open to participants now.
This study's enrollment of 50 is below the median of 300 across 36 observational studies indexed under Osteoporotic Fractures.
Browse Osteoporotic Fractures studies →Universidad de Valparaiso is the lead sponsor of 29 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The cohort will be:
Women and men over 50 years old
For both groups:
Inclusion Criteria:
Exclusion Criteria:
In case group/with fracture is added:
Inclusion criteria
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Measurement will be performed at radius and at tibia (ultra-distal and distal). For all the sites plus femoral neck, one measurement will be performed by DXA to get reference values of thickness and BMDs. For the distal positions and additional measurement will be performed by an innovative ultrasound device that estimates cortical thickness and porosity.
Cortical parameter measurement obtained by BDAT (Ultrasound)
Cortical thickness (mm) at one-third distal radius and mid-tibia
Time frame: Inclusion time
Cortical parameter measurement obtained by BDAT (Ultrasound)
Cortical porosity (%) at one-third distal radius and mid-tibia
Time frame: Inclusion time
Ultrasonic velocities measurement obtained by BDAT (Ultrasound)
velocity (m.s-1) of the First Arriving Signal (VFAS) at one-third distal radius and mid-tibia
Time frame: Inclusion time
Ultrasonic velocities measurement obtained by BDAT (Ultrasound)
velocity (m.s-1) of the A0 guided mode (A0) at one-third distal radius and mid-tibia
Time frame: Inclusion time
Quality measurement parameter obtained by BDAT (Ultrasound)
measurement at one-third distal radius and mid-tibia, normalized quality parameter (value ranging from 0 to 1).
Time frame: Inclusion time
femoral aBMD obtained by DXA
measurement of femoral areal Bone Mineral Density (aBMD g.cm-2).
Time frame: Inclusion time
Body composition measurements obtained by DXA
body composition: body fat, muscle and bone mass (kg).
Time frame: Inclusion time
10-year probability of fracture provided by FRAX algotithm
10-year probability of a major osteoporotic fracture, calculated with the femoral aBMD value.
Time frame: Inclusion time
10-year probability of fracture provided by FRAX algotithm
10-year probability of a major osteoporotic fracture, calculated without the femoral aBMD value.
Time frame: Inclusion time
This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidad de Valparaiso